The current study evaluated the effect of ERCC5 variants (rs751402 and rs1047768) on the clinical outcome of platinum-based regimens in non-small cell lung cancer (NSCLC) patients. This evidence concerns the gene ERCC5 and non-small cell lung carcinoma.